People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Hopewell Therapeutics, Inc. | — | Biotechnology | Series A | $25.9M | $7.5M | 2022 |
Xutian V. Jing at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Xutian V. Jing on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Howard Rosen | 1 | 5 |
| Thomas Hennessey | 1 | 3 |
| Qiaobing V. Xu | 1 | 1 |
| Thomas V. Hennessey, III | 1 | 1 |
| Xiaowen V. Femg | 1 | 1 |
| C. Thomas Paschall | 1 | 1 |
| Nan Shen | 1 | 1 |
| Qiaobing Xu | 1 | 1 |
| Jake Xia | 1 | 1 |
| Xutian Jing | 1 | 1 |
| THOMAS V HENNESSEY | 1 | 1 |
| JAKE V XIA | 1 | 1 |
| HOWARD V ROSEN | 1 | 1 |
| Nan V. Shen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.